查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948191

全球体学CRO服务市场：机会与策略展望（至2034年）

Omics CRO Services Global Market Opportunities And Strategies To 2034
出版日期: | 出版商: The Business Research Company | 英文 420 Pages | 商品交期: 2-10个工作天内

价格
简介目录

全球体学CRO服务市场预计到2024年将达到约342.0994亿美元，自2019年以来年复合成长率（CAGR）为13.55%。该市场预计将从2024年的342.0994亿美元成长到2029年的616.2889亿美元，年复合成长率为12.49%。此后，预计从2029年起将继续以10.77%的年复合成长率成长，到2034年达到1027.9404亿美元。

体学CRO（受託研究机构）服务是指外包研究解决方案，专门从事基因组学、转录组学、蛋白质组学、代谢体学和表观基因等领域的大规模生物数据分析。这些服务提供全面的支持，包括样本处理、高通量数据生成、生物资讯分析和解读，从而加速製药、生物技术和个人化医疗领域的研发。体学CRO服务的主要目标是使机构能够有效率地进行复杂的、高通量的体学研究，而无需对其自身基础设施进行大量投资。

体学CRO 服务市场由外包研究和分析服务组成，这些服务应用各种技术进行药物发现、精准医疗和生物标记识别，由组织、自僱人士或伙伴关係等营业单位提供。

有利的政府政策

过去，有利的政府政策推动了体学CRO服务市场的成长。这些政策，例如增加精准医疗的资金投入、津贴基因组研究以及构建支持性的法规结构，透过促进先进定序、生物标誌物发现和多组体学能力的拓展，体学CRO服务提供了支持。这些政策降低了CRO的财务和营运门槛，促进了创新和先进技术的应用。此外，政府支持的临床试验和数据共用计画加速了研究合作和全球服务部署。例如，2023年9月，美国国立卫生研究院（NIH）成立了一个联盟，初始资金为5,030万美元，旨在推动多体学研究，重点是整合各种体学资料类型，以研究不同人群的健康和疾病状况。这项措施为专注于多体学服务的CRO提供了机会。因此，有利的政府政策推动了体学CRO服务市场的成长。

策略联盟旨在加强技术整合

体学CRO服务市场的主要企业正在建立策略伙伴关係，以加强技术整合并扩大市场覆盖范围。策略伙伴关係通常指的是两个或多个组织为了实现通用目标而分享资源、专业知识和努力的合作关係。例如，2024年11月，总部位于美国的合约研究组织（CRO）Frontage Laboratories与总部位于波兰的临床和诊断服务供应商。此次策略合作旨在将Frontage的临床试验服务与Medicover先进的基因组检测解决方案结合。 Medicover在13个国家经营100多个实验室，提供全面的基因组分析服务，包括次世代定序（NGS）、分子病理学和药物基因组学。

全球体学CRO服务市场集中度较高，主要由主要企业主导。到2024年，排名前十的公司将占据15.12%的市场份额。

目录

第一章执行摘要

第二章 目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章 市场特征

  • 一般市场定义
  • 概述
  • 体学CRO服务市场定义与细分
  • 按体学服务类型分類的市场细分
    • 基因组学
    • 转录组学
    • 蛋白质体学
    • 代谢体学
    • 脂质组学
    • 多体学
    • 单细胞体学
    • 其他体学服务
  • 按技术平台划分：市场细分
    • 次世代定序（NGS）
    • 微阵列技术
    • 质谱分析
    • 层析法
    • 生物资讯学工具
    • 其他技术平台
  • 按应用领域划分：市场细分
    • 药物发现与开发
    • 诊断
    • 个人化医疗
    • 其他用途
  • 按最终用户划分：市场细分
    • 研究和学术机构
    • 製药和生物技术公司
    • 临床和诊断检测机构

第七章：主要市场趋势

  • 策略联盟旨在加强技术整合
  • 策略合作推进先进的空间转录组学
  • 下一代基于类器官的筛检解决方案

第八章 全球体学CRO服务成长分析及策略分析框架

  • 全球体学CRO服务PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用户分析（B2B）
    • 研究和学术机构
    • 製药和生物技术公司
    • 临床和诊断检查室
  • 全球体学CRO服务市场规模及成长分析
  • 2019-2024年市场成长表现
    • 2019-2024年市场驱动因素
    • 2019-2024年市场限制因素
  • 市场成长预测，2024-2029年，2034年预测
  • 预计成长要素/驱动力
    • 定量成长要素
    • 司机
    • 抑制因素
  • 最大潜在市场规模：体学CRO服务市场
    • TAM比较分析

9. 全球体学CRO服务市场：细分

  • 全球体学CRO服务市场：依体学服务类型划分，实际数据和预测数据（2019-2024年、2029年预测、2034年预测）。
  • 全球体学CRO服务市场依技术平台划分：实际值及预测值，2019-2024年、2029年预测值、2034年预测值
  • 全球体学CRO服务市场：按应用、效能和预测划分，2019-2024年、2029年预测、2034年预测
  • 全球体学CRO服务市场：依最终用户划分，实际数据和预测数据，2019-2024年、2029年预测值、2034年预测值
  • 全球体学CRO服务市场：依药物发现与开发、应用、绩效与预测进行细分（2019-2024年、2029年预测、2034年预测）。

第十章：中国市场

第十一章 日本市场

第十二章 欧洲市场

第十三章：美国市场

第十四章：加拿大市场

第十五章：全球竞争格局及公司概况

  • 公司简介
  • Labcorp Holding Inc. (including Covance)
  • Thermo Fisher Scientific Inc. (PPD)
  • Charles River Laboratories International Inc.
  • Eurofins Scientific SE
  • BGI Genomics Co. Ltd.

第十六章：其他领先和创新企业

  • Novogene Co. Ltd.
  • GENEWIZ from Azenta
  • Frontage Laboratories
  • Somalogic Inc.（SomaScan（R））
  • Metabolon Inc.

第十七章：全球十大公司的优势与劣势讯息

  • Labcorp Holding Inc. (including Covance)
  • Thermo Fisher Scientific Inc. (PPD)
  • Charles River Laboratories
  • Eurofins Scientific SE
  • BGI Genomics Co. Ltd.
  • Novogene Co. Ltd.
  • GENEWIZ from Azenta
  • Frontage Laboratories
  • Somalogic Inc. (SomaScan(R))
  • Metabolon Inc.

第十八章：全球十大公司人工智慧/机器学习能力资讯

  • Labcorp Holding Inc. (including Covance)
  • Thermo Fisher Scientific Inc. (PPD)
  • Charles River Laboratories
  • Eurofins Scientific SE
  • BGI Genomics Co. Ltd.
  • Novogene Co. Ltd.
  • GENEWIZ from Azenta
  • Frontage Laboratories
  • Somalogic Inc. (SomaScan(R))
  • Metabolon Inc.

第十九章：全球十大公司创新资讯（包括创新类型的描述）

  • Labcorp Holding Inc. (including Covance)
  • Thermo Fisher Scientific Inc. (PPD)
  • Charles River Laboratories
  • Eurofins Scientific SE
  • BGI Genomics Co. Ltd.
  • Novogene Co. Ltd.
  • GENEWIZ from Azenta
  • Frontage Laboratories
  • Somalogic Inc. (SomaScan(R))
  • Metabolon Inc.

第20章：全球排名前十的公司在其蛋白质组学、代谢体学和脂质组学平台/计划中具体采用的技术信息

  • Labcorp Holding Inc. (including Covance)
  • Thermo Fisher Scientific Inc. (PPD)
  • Charles River Laboratories
  • Eurofins Scientific SE
  • BGI Genomics Co. Ltd.
  • Novogene Co. Ltd.
  • GENEWIZ from Azenta
  • Frontage Laboratories
  • Somalogic Inc. (SomaScan(R))
  • Metabolon Inc.

第21章：全球前10大公司的全面能力和技术讯息，包括覆盖范围、动态范围、灵敏度和可重复性

  • Labcorp Holding Inc. (including Covance)
  • Thermo Fisher Scientific Inc. (PPD)
  • Charles River Laboratories
  • Eurofins Scientific SE
  • BGI Genomics Co. Ltd.
  • Novogene Co. Ltd.
  • GENEWIZ from Azenta
  • Frontage Laboratories
  • Somalogic Inc. (SomaScan(R))
  • Metabolon Inc.

第22章体学CRO服务市场的主要企业

第23章：欧洲竞争格局及公司概况

  • 公司简介
  • Charles River Laboratories International Inc.
  • Labcorp Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific SE.
  • BGI Genomics Co. Ltd.
  • Novogene Co. Ltd.
  • GENEWIZ from Azenta
  • Frontage Laboratories
  • Somalogic Inc.
  • Metabolon Inc.

第24章英国竞争格局及公司概况

  • 公司简介（简化版）
  • Eurofins Scientific SE
  • Charles River Laboratories Company
  • Labcorp Holding Inc.
  • Thermo Fisher Scientific Inc.
  • BGI Genomics Co. Ltd.
  • Novogene Co. Ltd.
  • GENEWIZ from Azenta
  • Frontage Laboratories
  • Metabolon Inc.
  • Somalogic Inc.

第25章 德国竞争格局及公司概况

  • 公司简介/产品与服务
  • Labcorp Holding Inc. (including Covance)
  • Thermo Fisher Scientific Inc. (PPD)
  • Eurofins Scientific SE
  • Charles River Laboratories
  • BGI Genomics Co. Ltd.
  • Novogene Co. Ltd.
  • GENEWIZ from Azenta
  • Somalogic Inc. (SomaScan(R))
  • Centogene GmbH
  • Frontage Laboratories

第26章 美国竞争格局与公司概况

  • 概述
  • Labcorp Holding Inc. (including Covance)
  • Thermo Fisher Scientific Inc. (PPD)
  • Charles River Laboratories
  • Eurofins Scientific SE
  • BGI Genomics Co. Ltd.
  • Novogene Co. Ltd.
  • GENEWIZ from Azenta
  • Frontage Laboratories
  • Somalogic Inc. (SomaScan(R))
  • Metabolon Inc.

第27章：日本的竞争格局与公司概况

  • 公司简介（简化版）
  • Eurofins Scientific SE
  • Charles River Laboratories
  • Thermo Fisher Scientific Inc. (PPD)
  • BGI Genomics Co. Ltd.
  • Labcorp Holding Inc. (including Covance)
  • Novogene Co. Ltd.
  • GENEWIZ from Azenta
  • Frontage Laboratories
  • Somalogic Inc. (SomaScan(R))
  • Centogene GmbH

第28章：主要体学CRO服务公司列表（按国家/地区划分）

  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲国家
  • 加拿大
  • 中国
  • 印度

第29章体学CRO服务市场技术平台中人工智慧/机器学习的当前活用状况

第三十章：主要客户公司列表

第31章 相对需求/服务规模

  • 目标检验
  • 风险降低计划
  • 从热门歌曲到热门歌曲
  • 生物标记鑑定
  • 改进製造工艺
  • 原料药分析
  • 毒性评价
  • 数据视觉化
  • 解读人工智慧/机器学习

第32章：AI/ML在体学CRO计划决策的应用频率

  • 基因组学：分析序列资料并识别遗传模式
  • 转录组学：RNA资料解读与表达定量
  • 蛋白质体学：蛋白质分类与修饰检测
  • 代谢体学：代谢谱分析和模式识别
  • 多体学整合：整合资料集并避免不良事件
  • 表观遗传学：人工智慧/机器学习在染色质和DNA修饰分析的应用
  • 微生物组学：人工智慧/机器学习在微生物组组成和功能的应用
  • 药物基因体学/毒理基因体学：人工智慧/机器学习在药物反应预测的应用
  • 单细胞体学：人工智慧/机器学习在细胞类型特异性分析的应用
  • 体学：人工智慧/机器学习在免疫库和免疫反应分析的应用

第33章体学CRO服务市场中未被满足的需求

第34章体学CRO服务市场的机会与挑战

第35章体学CRO服务市场的技术变革

第三十六章：你需要具备的竞争技能

第37章体学CRO服务市场的小规模企业

第38章：竞争标竿分析

第39章 竞争格局分析

第四十章 重大併购

  • Mapmygenome Acquired Microbiome Insights
  • Momentum Biotechnologies Acquired OmicScouts GmbH
  • Crown Bioscience Acquired Indivumed GmbH

第41章体学CRO服务市场的最新趋势

第42章 机会与策略

  • 2029年全球体学CRO服务市场：提供新机会的国家
  • 2029年全球体学CRO服务市场：新兴细分市场机会
  • 2029年全球体学CRO服务市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第43章体学CRO服务市场：结论与建议

  • 结论
  • 建议

第44章附录

简介目录
Product Code: PS5MOCSR01_O25Q4

Omics CRO (Contract Research Organization) services refer to outsourced research solutions specializing in large-scale biological data analysis in fields such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics. These services offer comprehensive support, encompassing sample processing, high-throughput data generation, bioinformatics analysis, and interpretation, to expedite research and development in pharmaceuticals, biotechnology, and personalized medicine. The primary purpose of omics CRO services is to enable organizations to conduct complex, high-volume omics studies efficiently without incurring significant investment in in-house infrastructure.

The omics CRO services market consists of sales, by entities (organizations, sole traders, or partnerships) of outsourced research and analytical services that apply different technologies for drug discovery, precision medicine, and biomarker identification.

The global omics CRO services market reached a value of nearly $34,209.94 million in 2024, having grown at a compound annual growth rate (CAGR) of 13.55% since 2019. The market is expected to grow from $34,209.94 million in 2024 to $61,628.89 million in 2029 at a rate of 12.49%. The market is then expected to grow at a CAGR of 10.77% from 2029 and reach $ 102,794.04 million in 2034.

Favorable Government Initiatives

During the historic period, the favorable government initiatives supported the growth of the omics CRO services market. Favorable government initiatives, such as increased funding for precision medicine, grants for genomics research, and supportive regulatory frameworks, help omics CRO services by enabling expansion of advanced sequencing, biomarker discovery, and multi-omics capabilities. These policies reduce financial and operational barriers for CROs, encouraging innovation and adoption of cutting-edge technologies. Additionally, government-backed programs for clinical trials and data sharing accelerate research collaborations and global service reach. For instance, in September 2023, the National Institutes of Health (NIH), a US-based government agency, established consortium with an initial funding of $50.3 million to advance multi-omics research, focusing on integrating various omics data types to study health and disease in diverse populations. This initiative provides opportunities for CROs specializing in multi-omics services. Therefore, the favorable government initiatives drove the growth of the omics CRO services market.

Strategic Collaborations To Enhance Technology Integration

Key companies operating in the omics CRO services market are adopting a strategic partnership approach to enhance technology integration and expand market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in November 2024, Frontage Laboratories, US-based contract research organization (CRO) providing integrated preclinical, clinical, and analytical services, partnered with Medicover Integrated Clinical Services (MICS), a Poland-based clinical and diagnostic services provider, his strategic partnership aims to integrate Frontage's clinical trial services with Medicover's advanced genomic testing solutions. Medicover, operating over 100 laboratories across 13 countries, provides comprehensive genomic analysis services, including next-generation sequencing (NGS), molecular pathology, and pharmacogenomics.

The global omics CRO services market is fairly concentrated, with a large player operating in the market. The top ten competitors in the market made up to 15.12% of the total market in 2024.

Omics CRO Services Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global omics CRO services market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for omics CRO services? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The omics CRO services market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider omics CRO services market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type of omics services, by technology platform, by application and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type of omics services, by technology platform, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for omics CRO services providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type Of Omics Services: Genomics; Transcriptomics; Proteomics; Metabolomics; Lipidomics; Multiomics; Single-Cell Omics; Other Type Of Omics Services
  • 2) By Technology Platform: Next-Generation Sequencing (NGS); Microarray Technology; Mass Spectrometry; Chromatography; Bioinformatics Tools; Other Technology Platforms
  • 3) By Application: Drug Discovery And Development; Diagnostics; Personalized Medicine; Other Applications
  • 4) By End Users: Research And Academic Institutions; Pharmaceutical And Biotechnology Companies; Clinical And Diagnostic Laboratories
  • Companies Mentioned: Labcorp Holding Inc. (including Covance); Thermo Fisher Scientific Inc. (PPD); Charles River Laboratories International Inc.; Eurofins Scientific SE; BGI Genomics Co. Ltd.
  • Countries: China; India; Japan; USA; Canada; UK; Germany; France; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; omics CRO services indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Omics CRO Services - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Omics CRO Services Market Definition And Segmentations
  • 6.4 Market Segmentation By Type Of Omics Services
    • 6.4.1 Genomics
    • 6.4.2 Transcriptomics
    • 6.4.3 Proteomics
    • 6.4.4 Metabolomics
    • 6.4.5 Lipidomics
    • 6.4.6 Multiomics
    • 6.4.7 Single-Cell Omics
    • 6.4.8 Other Type Of Omics Services
  • 6.5 Market Segmentation By Technology Platform
    • 6.5.1 Next-Generation Sequencing (NGS)
    • 6.5.2 Microarray Technology
    • 6.5.3 Mass Spectrometry
    • 6.5.4 Chromatography
    • 6.5.5 Bioinformatics Tools
    • 6.5.6 Other Technology Platforms
  • 6.6 Market Segmentation By Application
    • 6.6.1 Drug Discovery And Development
    • 6.6.2 Diagnostics
    • 6.6.3 Personalized Medicine
    • 6.6.4 Other Applications
  • 6.7 Market Segmentation By End Users
    • 6.7.1 Research And Academic Institutions
    • 6.7.2 Pharmaceutical And Biotechnology Companies
    • 6.7.3 Clinical And Diagnostic Laboratories

7 Major Market Trends

  • 7.1 Strategic Collaborations To Enhance Technology Integration
  • 7.2 Strategic Collaborations Driving Advanced Spatial Transcriptomics
  • 7.3 Next-Generation Organoid-Based Screening Solutions

8 Global Omics CRO Services Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Omics CRO Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 Analysis Of End Users (B2B)
    • 8.2.1 Research And Academic Institutions
    • 8.2.2 Pharmaceutical And Biotechnology Companies
    • 8.2.3 Clinical And Diagnostic Laboratories
  • 8.3 Global Omics CRO Services Market Size And Growth Analysis
  • 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Total Addressable Market for the Omics CRO Services Market
    • 8.7.1 TAM Comparison Analysis

9 Global Omics CRO Services Market Segmentation

  • 9.1 Global Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 China Market

  • 10.1 Market Overview
    • 10.1.1 Country Information
    • 10.1.2 Market Information
    • 10.1.3 Background Information
    • 10.1.4 Government Initiatives
    • 10.1.5 Regulations
    • 10.1.6 Regulatory Bodies
    • 10.1.7 Major Associations
    • 10.1.8 Taxes Levied
    • 10.1.9 Corporate Tax Structure
    • 10.1.10 Investments
    • 10.1.11 Major Companies
  • 10.2 China Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.3 China Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.4 China Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.5 China Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.6 China Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.7 India Market
  • 10.8 India Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.9 India Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.10 India Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.11 India Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.12 India Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Japan Market

  • 11.1 Market Overview
    • 11.1.1 Country Information
    • 11.1.2 Market Information
    • 11.1.3 Background Information
    • 11.1.4 Government Initiatives
    • 11.1.5 Regulations
    • 11.1.6 Regulatory Bodies
    • 11.1.7 Major Associations
    • 11.1.8 Taxes Levied
    • 11.1.9 Corporate Tax Structure
    • 11.1.10 Investments
    • 11.1.11 Major Companies
  • 11.2 Japan Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.3 Japan Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Japan Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Japan Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Japan Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Europe Market

  • 12.1 Market Overview
    • 12.1.1 Region Information
    • 12.1.2 Market Information
    • 12.1.3 Background Information
    • 12.1.4 Government Initiatives
    • 12.1.5 Regulations
    • 12.1.6 Regulatory Bodies
    • 12.1.7 Major Associations
    • 12.1.8 Taxes Levied
    • 12.1.9 Corporate Tax Structure
    • 12.1.10 Investments
    • 12.1.11 Major Companies
  • 12.2 Europe Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.3 Europe Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Europe Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Europe Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Europe Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.7 Europe Omics CRO Services Market: Country Analysis
  • 12.8 UK Market
  • 12.9 UK Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 UK Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.12 UK Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 UK Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Market
  • 12.15 Germany Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.16 Germany Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 Germany Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 Germany Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Germany Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.20 France Market
  • 12.21 France Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 France Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 France Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.24 France Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 France Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Italy Market
  • 12.27 Italy Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.28 Italy Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.29 Italy Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.30 Italy Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.31 Italy Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.32 Spain Market
  • 12.33 Spain Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.34 Spain Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.35 Spain Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.36 Spain Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.37 Spain Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.38 Rest Of Europe Market
  • 12.39 Rest Of Europe Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.40 Rest Of Europe Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.41 Rest Of Europe Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.42 Rest Of Europe Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.43 Rest Of Europe Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 USA Market

  • 13.1 Market Overview
    • 13.1.1 Country Information
    • 13.1.2 Market Information
    • 13.1.3 Background Information
    • 13.1.4 Government Initiatives
    • 13.1.5 Regulations
    • 13.1.6 Regulatory Bodies
    • 13.1.7 Major Associations
    • 13.1.8 Taxes Levied
    • 13.1.9 Corporate Tax Structure
    • 13.1.10 Investments
    • 13.1.11 Major Companies
  • 13.2 USA Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.3 USA Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 USA Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 USA Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 USA Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 Canada Market

  • 14.1 Market Overview
    • 14.1.1 Country Information
    • 14.1.2 Market Information
    • 14.1.3 Background Information
    • 14.1.4 Government Initiatives
    • 14.1.5 Regulations
    • 14.1.6 Regulatory Bodies
    • 14.1.7 Major Associations
    • 14.1.8 Taxes Levied
    • 14.1.9 Corporate Tax Structure
    • 14.1.10 Investments
    • 14.1.11 Major Companies
  • 14.2 Canada Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.3 Canada Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 Canada Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 Canada Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 Canada Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 Global Competitive Landscape And Company Profiles

  • 15.1 Company Profiles
  • 15.2 Labcorp Holding Inc. (including Covance)
    • 15.2.1 Company Overview
    • 15.2.2 Products And Services
    • 15.2.3 Financial Overview
  • 15.3 Thermo Fisher Scientific Inc. (PPD)
    • 15.3.1 Company Overview
    • 15.3.2 Products And Services
    • 15.3.3 Business Strategy
    • 15.3.4 Financial Overview
  • 15.4 Charles River Laboratories International Inc.
    • 15.4.1 Company Overview
    • 15.4.2 Products And Services
    • 15.4.3 Financial Overview
  • 15.5 Eurofins Scientific SE
    • 15.5.1 Company Overview
    • 15.5.2 Products And Services
    • 15.5.3 Financial Overview
  • 15.6 BGI Genomics Co. Ltd.
    • 15.6.1 Company Overview
    • 15.6.2 Products And Services
    • 15.6.3 Financial Overview

16 Other Major And Innovative Companies

  • 16.1 Novogene Co. Ltd.
    • 16.1.1 Company Overview
    • 16.1.2 Products And Services
  • 16.2 GENEWIZ from Azenta
    • 16.2.1 Company Overview
    • 16.2.2 Products And Services
  • 16.3 Frontage Laboratories
    • 16.3.1 Company Overview
    • 16.3.2 Products And Services
  • 16.4 Somalogic Inc. (SomaScan(R))
    • 16.4.1 Company Overview
    • 16.4.2 Products And Services
  • 16.5 Metabolon Inc.
    • 16.5.1 Company Overview
    • 16.5.2 Products And Services

17 Information On Strengths And Weaknesses Of Top 10 Global Companies

  • 17.1 Labcorp Holding Inc. (including Covance)
    • 17.1.1 Strengths
    • 17.1.2 Weaknesses
  • 17.2 Thermo Fisher Scientific Inc. (PPD)
    • 17.2.1 Strengths
    • 17.2.2 Weaknesses
  • 17.3 Charles River Laboratories
    • 17.3.1 Strengths
    • 17.3.2 Weaknesses
  • 17.4 Eurofins Scientific SE
    • 17.4.1 Strengths
    • 17.4.2 Weaknesses
  • 17.5 BGI Genomics Co. Ltd.
    • 17.5.1 Strengths
    • 17.5.2 Weaknesses
  • 17.6 Novogene Co. Ltd.
    • 17.6.1 Strengths
    • 17.6.2 Weaknesses
  • 17.7 GENEWIZ from Azenta
    • 17.7.1 Strengths
    • 17.7.2 Weaknesses
  • 17.8 Frontage Laboratories
    • 17.8.1 Strengths
    • 17.8.2 Weaknesses
  • 17.9 Somalogic Inc. (SomaScan(R))
    • 17.9.1 Strengths
    • 17.9.2 Weaknesses
  • 17.10 Metabolon Inc.
    • 17.10.1 Strengths
    • 17.10.2 Weaknesses

18 Information On AI/ML Capabilities Of Top 10 Global Companies

  • 18.1 Labcorp Holding Inc. (Including Covance)
    • 18.1.1 Bioinformatics And Genomics Pipelines (NGS, Expression, Multi-Omics)
    • 18.1.2 Clinical and Real-World Data (RWD) with Predictive Analytics
    • 18.1.3 Digital Pathology And Image-Based AI
    • 18.1.4 Cloud Infrastructure and Generative-AI Clinician Tools
    • 18.1.5 Partnerships And External AI/ML Collaborations
  • 18.2 Thermo Fisher Scientific Inc. (PPD)
    • 18.2.1 Accelerator(TM) Drug Development Platform
    • 18.2.2 AI-Powered Clinical Trial Forecasting
    • 18.2.3 PPD(TM) TrueCast AI Solution
    • 18.2.4 Partnership with OpenAI
    • 18.2.5 Integration of AI in Laboratory Services
  • 18.3 Charles River Laboratories
    • 18.3.1 Logica: AI-Powered Drug Discovery Platform
    • 18.3.2 Collaborations with Aitia and Related Sciences
    • 18.3.3 Integration of Omics and New Approach Methodologies
  • 18.4 Eurofins Scientific SE
    • 18.4.1 Eurofins DiscoveryAI: SAFIRE Platform
    • 18.4.2 Eurofins Viracor Bioinformatics & AI Center of Excellence
    • 18.4.3 Cloud-Based Data Analysis Infrastructure
  • 18.5 BGI Genomics Co. Ltd.
    • 18.5.1 GeneT: AI-Powered Genomic Consultation Platform
    • 18.5.2 iGeneT Pro: Comprehensive Bioinformatics Analysis
    • 18.5.3 133111i Multi-Omics Precision Health Management System
    • 18.5.4 Dr. Tom: Multi-Omics Data Visualization System
    • 18.5.5 Multi-Omics Services for Research and Drug Discovery
  • 18.6 Novogene Co. Ltd.
    • 18.6.1 NovoMagic: Cloud-Based Bioinformatics Platform
    • 18.6.2 Novi: AI-Powered RNA-Seq Analysis Assistant
    • 18.6.3 C2-Intelligence Platform: AI-Powered Cancer Detection
    • 18.6.4 Multi-Omics Services for Research and Drug Discovery
  • 18.7 GENEWIZ from Azenta
    • 18.7.1 Strategic Partnership with Form Bio
    • 18.7.2 Advanced Sequencing Technologies
    • 18.7.3 3. Comprehensive Bioinformatics Solutions
    • 18.7.4 Multi-Omics Services for Research and Drug Discovery
  • 18.8 Frontage Laboratories
    • 18.8.1 Genomics and Omics Services
    • 18.8.2 Drug Discovery and Development Services
    • 18.8.3 Biomarker and Precision Medicine
    • 18.8.4 AI/ML Integration in Omics Services
  • 18.9 Somalogic Inc. (SomaScan(R))
    • 18.9.1 AI/ML Integration in SomaScan(R) Proteomics
    • 18.9.2 Omics CRO Servicesand Capabilities
    • 18.9.3 High-Throughput Proteomics
    • 18.9.4 Biomarker Discovery
    • 18.9.5 Clinical and Translational Research
  • 18.10 Metabolon Inc.
    • 18.10.1 Automate Data Curation
    • 18.10.2 Identify Biochemical Signatures
    • 18.10.3 Anomaly Detection

19 Information On Innovations By Top 10 Global Companies Including Description Of Type Of Innovation

  • 19.1 Labcorp Holding Inc. (Including Covance)
    • 19.1.1 Next-Generation Sequencing (NGS) Panel Advancements
  • 19.2 Thermo Fisher Scientific Inc. (PPD)
    • 19.2.1 Expansion of Bioanalytical Laboratory Services in Europe
    • 19.2.2 R&D Partnership with AstraZeneca BioVentureHub
  • 19.3 Charles River Laboratories
    • 19.3.1 Omics and New Approach Methodologies (NAMs) Integration
    • 19.3.2 Automation in Spatial Biology
  • 19.4 Eurofins Scientific SE
    • 19.4.1 Partnership with Hurdle to Enhance Omics Testing Access
    • 19.4.2 Integration of Omics Technologies with New Approach Methodologies (NAMs)
  • 19.5 BGI Genomics Co. Ltd.
    • 19.5.1 Collaboration with Saudi Arabia's National Unified Procurement Company
  • 19.6 Novogene Co. Ltd.
    • 19.6.1 Launch of Spatial Transcriptomics Service
    • 19.6.2 Establishment of Novogene Korea Limited
    • 19.6.3 Certification as Olink(R) Certified Service Provider
  • 19.7 GENEWIZ from Azenta
    • 19.7.1 Launch of Clinical Long-Read Whole Genome Sequencing Test
    • 19.7.2 Strategic Partnership with Form Bio for AAV Gene Therapy
    • 19.7.3 GENEWIZ Week 2025 Workshops
  • 19.8 Frontage Laboratories
    • 19.8.1 Strategic Collaboration with Medicover Integrated Clinical Services
    • 19.8.2 Participation in the 2025 EMGS Annual Meeting
    • 19.8.3 Expansion of Global Drug Discovery and DMPK Leadership
  • 19.9 Somalogic Inc. (SomaScan(R))
    • 19.9.1 Expansion of SomaScan(R) 11K Platform
    • 19.9.2 Early Access Program with Illumina Sequencers
    • 19.9.3 SomaScan(R) Assay Powers Key Insights into Semaglutide Treatment
    • 19.9.4 Illumina's Acquisition of SomaLogic
  • 19.10 Metabolon Inc.
    • 19.10.1 Launch of Integrated Bioinformatics Platform
    • 19.10.2 Introduction of 4-Week Turnaround Time for Commercial Projects
    • 19.10.3 Launch of Microbiome Research Solution
    • 19.10.4 Expansion of Integrated Bioinformatics Platform

20 Information On Technologies Used Specifically For Proteomics, Metabolomics And Lipidomics Platforms/Projects By Top 10 Global Companies

  • 20.1 Labcorp Holding Inc. (including Covance)
    • 20.1.1 Proteomics Technologies
    • 20.1.2 Metabolomics Technologies
    • 20.1.3 Lipidomics Technologies
  • 20.2 Thermo Fisher Scientific Inc.
    • 20.2.1 Proteomics Technologies
    • 20.2.2 Metabolomics Technologies
    • 20.2.3 Lipidomics Technologies
  • 20.3 Charles River Laboratories
    • 20.3.1 Proteomics Technologies
    • 20.3.2 Metabolomics Technologies
    • 20.3.3 Lipidomics Technologies
  • 20.4 Eurofins Scientific SE
    • 20.4.1 Proteomics Technologies
    • 20.4.2 Metabolomics Technologies
    • 20.4.3 Lipidomics Technologies
  • 20.5 BGI Genomics Co. Ltd.
    • 20.5.1 Proteomics Technologies
    • 20.5.2 Metabolomics Technologies
    • 20.5.3 Lipidomics Technologies
  • 20.6 Novogene Co. Ltd.
    • 20.6.1 Proteomics Technologies
    • 20.6.2 Metabolomics Technologies
    • 20.6.3 Lipidomics Technologies
  • 20.7 GENEWIZ from Azenta
    • 20.7.1 Proteomics Technologies
    • 20.7.2 Metabolomics Technologies:
    • 20.7.3 Lipidomics Technologies:
  • 20.8 Frontage Laboratories
    • 20.8.1 Proteomics Technologies
    • 20.8.2 Metabolomics Technologies
    • 20.8.3 Lipidomics Technologies
  • 20.9 Somalogic Inc. (SomaScan)
    • 20.9.1 Proteomics Technologies
    • 20.9.2 Metabolomics Technologies
    • 20.9.3 Lipidomics Technologies
  • 20.10 Metabolon Inc.
    • 20.10.1 Proteomics Technologies
    • 20.10.2 Metabolomics Technologies
    • 20.10.3 Lipidomics Technologies

21 Information On Overall Capabilities And Technologies Including Coverage, Dynamic Range, Sensitivity And Reproducibility For Top 10 Global Companies

  • 21.1 Labcorp Holding Inc. (including Covance)
    • 21.1.1 Overall Capabilities & Technologies
    • 21.1.2 Coverage
    • 21.1.3 Dynamic Range
    • 21.1.4 Sensitivity
    • 21.1.5 Reproducibility
  • 21.2 Thermo Fisher Scientific Inc. (PPD)
    • 21.2.1 Overall Capabilities & Technologies
    • 21.2.2 Coverage
    • 21.2.3 Dynamic Range
    • 21.2.4 Sensitivity
    • 21.2.5 Reproducibility
  • 21.3 Charles River Laboratories
    • 21.3.1 Overall Capabilities & Technologies
    • 21.3.2 Coverage
    • 21.3.3 Dynamic Range
    • 21.3.4 Sensitivity
    • 21.3.5 Reproducibility
  • 21.4 Eurofins Scientific SE
    • 21.4.1 Overall Capabilities & Technologies
    • 21.4.2 Coverage
    • 21.4.3 Dynamic Range
    • 21.4.4 Sensitivity
    • 21.4.5 Reproducibility
  • 21.5 BGI Genomics Co. Ltd.
    • 21.5.1 Overall Capabilities & Technologies
    • 21.5.2 Coverage
    • 21.5.3 Dynamic Range
    • 21.5.4 Sensitivity
    • 21.5.5 Reproducibility
  • 21.6 Novogene Co. Ltd.
    • 21.6.1 Overall Capabilities & Technologies
    • 21.6.2 Coverage
    • 21.6.3 Dynamic Range
    • 21.6.4 Sensitivity
    • 21.6.5 Reproducibility
  • 21.7 GENEWIZ from Azenta
    • 21.7.1 Overall Capabilities & Technologies
    • 21.7.2 Coverage
    • 21.7.3 Dynamic Range
    • 21.7.4 Sensitivity
    • 21.7.5 Reproducibility
  • 21.8 Frontage Laboratories
    • 21.8.1 Overall Capabilities & Technologies
    • 21.8.2 Coverage
    • 21.8.3 Dynamic Range
    • 21.8.4 Sensitivity
    • 21.8.5 Reproducibility
  • 21.9 Somalogic Inc. (SomaScan)
    • 21.9.1 Overall Capabilities & Technologies
    • 21.9.2 Coverage
    • 21.9.3 Dynamic Range
    • 21.9.4 Sensitivity
    • 21.9.5 Reproducibility
  • 21.10 Metabolon Inc.
    • 21.10.1 Overall Capabilities & Technologies
    • 21.10.2 Coverage
    • 21.10.3 Dynamic Range
    • 21.10.4 Sensitivity
    • 21.10.5 Reproducibility

22 List Of Key Players In The Omics CRO Services Market

  • 22.1 Key Players In The Omics Contract Research Organization (CRO) Services Market

23 Europe Competitive Landscape And Company Profiles

  • 23.1 Company Profiles
  • 23.2 Charles River Laboratories International Inc.
    • 23.2.1 Company Overview
    • 23.2.2 Products And Services
  • 23.3 Labcorp Holdings Inc.
    • 23.3.1 Company Overview
    • 23.3.2 Products And Services
  • 23.4 Thermo Fisher Scientific Inc.
    • 23.4.1 Company Overview
    • 23.4.2 Products And Services
  • 23.5 Eurofins Scientific SE.
    • 23.5.1 Company Overview
    • 23.5.2 Products And Services
  • 23.6 BGI Genomics Co. Ltd.
    • 23.6.1 Company Overview
    • 23.6.2 Products And Services
  • 23.7 Novogene Co. Ltd.
    • 23.7.1 Company Overview
    • 23.7.2 Products And Services
  • 23.8 GENEWIZ from Azenta
    • 23.8.1 Company Overview
    • 23.8.2 Products And Services
  • 23.9 Frontage Laboratories
    • 23.9.1 Company Overview
    • 23.9.2 Products And Services
  • 23.10 Somalogic Inc.
    • 23.10.1 Company Overview
    • 23.10.2 Products And Services
  • 23.11 Metabolon Inc.
    • 23.11.1 Company Overview
    • 23.11.2 Products And Services

24 UK Competitive Landscape And Company Profiles

  • 24.1 Short Profiles
  • 24.2 Eurofins Scientific SE
    • 24.2.1 Company Overview
    • 24.2.2 Products And Services
  • 24.3 Charles River Laboratories Company
    • 24.3.1 Company Overview
    • 24.3.2 Products And Services
  • 24.4 Labcorp Holding Inc.
    • 24.4.1 Company Overview
    • 24.4.2 Products And Services
  • 24.5 Thermo Fisher Scientific Inc.
    • 24.5.1 Company Overview
    • 24.5.2 Products And Services
  • 24.6 BGI Genomics Co. Ltd.
    • 24.6.1 Company Overview
    • 24.6.2 Products And Services
  • 24.7 Novogene Co. Ltd.
    • 24.7.1 Company Overview
    • 24.7.2 Products And Services
  • 24.8 GENEWIZ from Azenta
    • 24.8.1 Company Overview
    • 24.8.2 Products And Services
  • 24.9 Frontage Laboratories
    • 24.9.1 Company Overview
    • 24.9.2 Products And Services
  • 24.10 Metabolon Inc.
    • 24.10.1 Company Overview
    • 24.10.2 Products And Services
  • 24.11 Somalogic Inc.
    • 24.11.1 Company Overview
    • 24.11.2 Products And Services

25 Germany Competitive Landscape And Company Profiles

  • 25.1 Short Profiles
  • 25.2 Labcorp Holding Inc. (including Covance)
    • 25.2.1 Company Overview
    • 25.2.2 Products And Services
  • 25.3 Thermo Fisher Scientific Inc. (PPD)
    • 25.3.1 Company Overview
    • 25.3.2 Products And Services
  • 25.4 Eurofins Scientific SE
    • 25.4.1 Company Overview
    • 25.4.2 Products And Services
  • 25.5 Charles River Laboratories
    • 25.5.1 Company Overview
    • 25.5.2 Products And Services
  • 25.6 BGI Genomics Co. Ltd.
    • 25.6.1 Company Overview
    • 25.6.2 Products And Services
  • 25.7 Novogene Co. Ltd.
    • 25.7.1 Company Overview
    • 25.7.2 Products And Services
  • 25.8 GENEWIZ from Azenta
    • 25.8.1 Company Overview
    • 25.8.2 Products And Services
  • 25.9 Somalogic Inc. (SomaScan(R))
    • 25.9.1 Company Overview
    • 25.9.2 Products And Services
  • 25.10 Centogene GmbH
    • 25.10.1 Company Overview
    • 25.10.2 Products And Services
  • 25.11 Frontage Laboratories
    • 25.11.1 Company Overview
    • 25.11.2 Products And Services

26 USA Competitive Landscape And Company Profiles

  • 26.1 Short Profiles
  • 26.2 Labcorp Holding Inc. (including Covance)
    • 26.2.1 Company Overview
    • 26.2.2 Products And Services
  • 26.3 Thermo Fisher Scientific Inc. (PPD)
    • 26.3.1 Company Overview
    • 26.3.2 Products And Services
  • 26.4 Charles River Laboratories
    • 26.4.1 Company Overview
    • 26.4.2 Products And Services
  • 26.5 Eurofins Scientific SE
    • 26.5.1 Company Overview
    • 26.5.2 Products And Services
  • 26.6 BGI Genomics Co. Ltd.
    • 26.6.1 Company Overview
    • 26.6.2 Products And Services
  • 26.7 Novogene Co. Ltd.
    • 26.7.1 Company Overview
    • 26.7.2 Products And Services
  • 26.8 GENEWIZ from Azenta
    • 26.8.1 Company Overview
    • 26.8.2 Products And Services
  • 26.9 Frontage Laboratories
    • 26.9.1 Company Overview
    • 26.9.2 Products And Services
  • 26.10 Somalogic Inc. (SomaScan(R))
    • 26.10.1 Company Overview
    • 26.10.2 Products And Services
  • 26.11 Metabolon Inc.
    • 26.11.1 Company Overview
    • 26.11.2 Products And Services

27 Japan Competitive Landscape And Company Profiles

  • 27.1 Short Profiles
  • 27.2 Eurofins Scientific SE
    • 27.2.1 Company Overview
    • 27.2.2 Products And Services
  • 27.3 Charles River Laboratories
    • 27.3.1 Company Overview
    • 27.3.2 Products And Services
  • 27.4 Thermo Fisher Scientific Inc. (PPD)
    • 27.4.1 Company Overview
    • 27.4.2 Products And Services
  • 27.5 BGI Genomics Co. Ltd.
    • 27.5.1 Company Overview
    • 27.5.2 Products And Services
  • 27.6 Labcorp Holding Inc. (including Covance)
    • 27.6.1 Company Overview
    • 27.6.2 Products And Services
  • 27.7 Novogene Co. Ltd.
    • 27.7.1 Company Overview
    • 27.7.2 Products And Services
  • 27.8 GENEWIZ from Azenta
    • 27.8.1 Company Overview
    • 27.8.2 Products And Services
  • 27.9 Frontage Laboratories
    • 27.9.1 Company Overview
    • 27.9.2 Products And Services
  • 27.10 Somalogic Inc. (SomaScan(R))
    • 27.10.1 Company Overview
    • 27.10.2 Products And Services
  • 27.11 Centogene GmbH
    • 27.11.1 Company Overview
    • 27.11.2 Products And Services

28 List Of Key Omics CRO Services Companies For The Countries

    • 28.1.1 France
    • 28.1.2 Italy
    • 28.1.3 Spain
    • 28.1.4 Rest Of Europe
    • 28.1.5 Canada
    • 28.1.6 China
    • 28.1.7 India

29 Current Uses Of AI/ML In Technology Platforms In Omics CRO Services Market

  • 29.1 Next-Generation Sequencing (NGS)
  • 29.2 Microarray Technology
  • 29.3 Mass Spectrometry
  • 29.4 Chromatography
  • 29.5 Bioinformatics Tools
  • 29.6 Other Technology Platforms

30 List Of Largest Customer Companies

31 Relative Demand/Size Of Service

  • 31.1 Target Validation
  • 31.2 De-Risking Projects
  • 31.3 Hit-To-Lead
  • 31.4 Biomarker Identification
  • 31.5 Manufacturing Process Improvements
  • 31.6 Drug Substance Analysis
  • 31.7 Toxicology Evaluations
  • 31.8 Visualization Of Data
  • 31.9 AI/ML Interpretations

32 Usage Frequency Of AI/ML In Decision Making Across Omics CRO Projects

  • 32.1 Genomics: Analyze Sequencing Data, And Identify Gene Patterns
  • 32.2 Transcriptomics: Interpret RNA Data, And Quantify Expression
  • 32.3 Proteomics: Classify Proteins, And Detect Modifications
  • 32.4 Metabolomics: Analyze Metabolite Profiles, And Identify Patterns
  • 32.5 Multi-Omics Integration: Integrate Datasets, And Avoid Outcome Incidents
  • 32.6 Epigenomics: AI/ML in Chromatin & DNA Modification Analysis
  • 32.7 Microbiomics: AI/ML in Microbiome Composition and Function
  • 32.8 Pharmacogenomics & Toxicogenomics: AI/ML in Drug Response Prediction
  • 32.9 Single-Cell Omics: AI/ML in Cell-Type Specific Analysis
  • 32.10 Immunomics: AI/ML in Immune Repertoire and Immune Response Profiling

33 Unmet Needs Of The Omics CRO Services Market

  • 33.1 Complexity and High Standards
  • 33.2 Customized, Client-Centric Solutions
  • 33.3 Efficient Data Management and Security
  • 33.4 Faster, Cost-Effective Turnaround
  • 33.5 Comprehensive Coverage Across Drug Development Phases
  • 33.6 Patient Stratification and Recruitment

34 Opportunities And Threats To The Omics CRO Services Market

  • 34.1 Opportunities
    • 34.1.1 Expansion of Precision and Personalized Medicine
    • 34.1.2 Rising Adoption of AI and Data Analytics
    • 34.1.3 Increasing Outsourcing by Biotech and Pharma Firms
    • 34.1.4 Growing Global Demand for Multi-omics Clinical Trials
    • 34.1.5 Investment and Partnerships Across Emerging Markets
  • 34.2 Threats
    • 34.2.1 High Cost and Complexity of Omics Technologies
    • 34.2.2 Data Integration Challenges
    • 34.2.3 Talent scarcity
    • 34.2.4 Ethical And Privacy Concerns
    • 34.2.5 Rising competition

35 Technologies Change In The Omics CRO Services Market

  • 35.1 Mass Spectrometry (MS) Platforms
  • 35.2 Chromatography Systems
  • 35.3 Bioinformatics and Data Analysis Pipelines
  • 35.4 Sample Preparation and Handling Technologies
  • 35.5 Proteomics Quantitation Methods
  • 35.6 Metabolomics and Lipidomics Platforms
  • 35.7 Multi-Omics Integration Tools
  • 35.8 Data Storage and Sharing Technologies

36 Expertise Necessary To Compete In The Omics CRO Services Market

  • 36.1 Core Technical Expertise
  • 36.2 Multi-Omics Data Integration
  • 36.3 End-to-End Service Delivery
  • 36.4 Regulatory and Domain Knowledge
  • 36.5 Emerging Trends and Strategic Positioning

37 Small Players In The Omics CRO Services Market

  • 37.1 North America
    • 37.1.1 Dalton Bioanalytics
    • 37.1.2 Sapient Bioanalytics
    • 37.1.3 MS Bioworks Company
    • 37.1.4 Panome Bio
    • 37.1.5 Allumiqs
  • 37.2 Europe
    • 37.2.1 OmicScouts GmbH
    • 37.2.2 Sciomics GmbH
    • 37.2.3 PreOmics GmbH
    • 37.2.4 Biognosys AG
    • 37.2.5 GenomeScan

38 Competitive Benchmarking

39 Competitive Dashboard

40 Key Mergers And Acquisitions

  • 40.1 Mapmygenome Acquired Microbiome Insights
  • 40.2 Momentum Biotechnologies Acquired OmicScouts GmbH
  • 40.3 Crown Bioscience Acquired Indivumed GmbH

41 Recent Development In Omics CRO Services Market

  • 41.1 Cutting-Edge Facility Supports End-to-End Multi-Omics Research and Product InnovationI

42 Opportunities And Strategies

  • 42.1 Global Omics CRO Services Market In 2029 - Countries Offering Most New Opportunities
  • 42.2 Global Omics CRO Services Market In 2029 - Segments Offering Most New Opportunities
  • 42.3 Global Omics CRO Services Market In 2029 - Growth Strategies
    • 42.3.1 Market Trend Based Strategies
    • 42.3.2 Competitor Strategies

43 Omics CRO Services Market, Conclusions And Recommendations

  • 43.1 Conclusions
  • 43.2 Recommendations
    • 43.2.1 Product
    • 43.2.2 Place
    • 43.2.3 Price
    • 43.2.4 Promotion
    • 43.2.5 People

44 Appendix

  • 44.1 Geographies Covered
  • 44.2 Market Data Sources
  • 44.3 Research Methodology
  • 44.4 Currencies
  • 44.5 The Business Research Company
  • 44.6 Copyright and Disclaimer